Evidence map›Paper›PMID 41603330›Full record

ArticleJournal of Alzheimer's disease : JAD2026

Assessing technologies in dementia care: A conceptual health-economic model.

Jinjing Fu, Ron Handels, Matthieu Arendse, Teis Arets, Ellis Bartholomeus, Marco Blom, Sascha Bolt, Tibor Bosse, Roel Boumans, Debby Gerritsen and 11 more

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Jinjing FuUniversity of Groningen, Department of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands.ORCID 0009-0003-0084-3155
Ron HandelsAlzheimer Centre Limburg, Faculty of Health Medicine and Life Sciences, Mental Health and Neuroscience Research Institute, Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands.
Matthieu ArendseTanteLouise, Bergen op Zoom, AB, The Netherlands.
Teis AretsDepartment of Industrial Engineering & Innovation Sciences, Eindhoven University of Technology, Eindhoven, The Netherlands.
Ellis BartholomeusDepartment of Industrial Engineering & Innovation Sciences, Eindhoven University of Technology, Eindhoven, The Netherlands.
Marco BlomAlzheimer Nederland, Amersfoort, The Netherlands.
Sascha BoltTilburg School of Social and Behavioral Sciences, Tilburg University, Tilburg, The Netherlands.
Tibor BosseBehavioural Science Institute, Radboud University, Nijmegen, The Netherlands.
Roel BoumansBehavioural Science Institute, Radboud University, Nijmegen, The Netherlands.
Debby GerritsenDepartment of Primary and Community Care, Radboudumc Alzheimer Center, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
Hans ArnoldTIGNL BV, Technology Investment Group/JAIN Foundation, Gorinchem, The Netherlands.
Wijnand IJsselsteijnDepartment of Industrial Engineering & Innovation Sciences, Eindhoven University of Technology, Eindhoven, The Netherlands.
Anne KolmansDepartment of Primary and Community Care, Radboudumc, Nijmegen, The Netherlands.ORCID 0009-0000-8910-134X
Henk Herman NapNational Center of Expertise for Long-term Care, Vilans, Utrecht, The Netherlands.
Baran PolatBehavioural Science Institute, Radboud University, Nijmegen, The Netherlands.
Paul Raingeard de la BlétièreDepartment of Industrial Design Engineering, Delft University of Technology, Delft, The Netherlands.
Rebecca S SchaeferInstitute of Psychology, Health, Medical, & Neuropsychology Unit, Leiden University, Leiden, The Netherlands.
Dirk SteijgerAlzheimer Centre Limburg, Faculty of Health Medicine and Life Sciences, Mental Health and Neuroscience Research Institute, Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands.
Sander OsstynAlzheimer Centre Limburg, Faculty of Health Medicine and Life Sciences, Mental Health and Neuroscience Research Institute, Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands.
Marjolein de VugtAlzheimer Centre Limburg, Faculty of Health Medicine and Life Sciences, Mental Health and Neuroscience Research Institute, Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands.
Erik BuskensUniversity of Groningen, Department of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundTechnologies such as assistive devices and social robots show promise in supporting people with dementia and their caregivers. However, their long-term cost-effectiveness remains unclear, and existing health-economic models are limited in capturing the relevant outcomes.ObjectiveThis study aims to conceptualize a health-economic model to assess the potential impact of care technologies in dementia care on lifetime quality of life and care use.MethodsWe summarized an impact pathway of three care technologies and conceptualized a health-economic model to estimate the long-term impact on quality of life and care use, drawing on literature and multidisciplinary expert input.ResultsWe conceptualized a cohort-based Markov state-transition model simulating states of dementia severity progression (mild, moderate, severe), care setting transitions (no formal care, home care, nursing home), and mortality. Intervention effects are modeled through surrogate outcomes such as functional status and caregiver burden associated to care transitions and quality of life.ConclusionsThis model offers a framework for early health technology assessment of assistive technologies in dementia, supporting extrapolation of effects beyond limited trial data. Future work should focus on developing and operationalizing this model, applying it to establish the value of dementia care technologies.

Indexed as

DementiaModels, EconomicSelf-Help DevicesTechnology Assessment, BiomedicalCaregiversCost-Benefit AnalysisHumansMarkov ChainsQuality of LifeAlzheimer's diseasecost-effectivenessdementiahealth-economic modelnon-pharmacological interventionspsychosocial interventionsquality of life

Identifiers

PMID41603330
PMCPMC12960762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.